headlines - RSS Feed Directory

abortion
acid reflux
adhd
alcohol treatment
allergy
alternative medicine
alzheimers dimentia
anxiety phobia
arthritis
asthma respiratory
autism
bacteria viral
biochemistry biology
bipolar
bird flu avian flu
blood hematology
body aches
breast cancer
cancer oncology
cardiovascular cardiology
cholesterol
cleft palate
clinical drug trials
colorectal cancer
compliance
cosmetic plastic surgery
cystic fibrosis
dentistry
depression
dermatology
diabetes
disaster aid
dyslexia
ear nose throat
endocrinology
epilepsy
erectile dysfunction premature ejaculation
eye health opthamology
fertility
fitness obesity
flu sars
gastrointestinal
genetics
gout
headlines
health insurance
hearing deafness
hiv aids
homecare caregivers
huntingtons disease
hypertension
immune system
internet
irritable bowel syndrome
liver disease hepatitis
lung cancer
lupus
lymphoma leukemia
mad cow disease
medical conference
medical devices
medical malpractice
medical students
medicare medicaid
mens health
mental health
migraine headache
mri pet scan
mrsa super bug
multiple sclerosis
muscular dystrophy
neurology neuroscience
nursing
nutrition agriculture
organ transplants donation
orthopaedics
pain
parkinsons disease
pediatrics
pharmaceutical industry
pregnancy
primary care
prostrate
psychology psychiatry
public health
radiology
rehabilitation
schizophrenia
senior aging
sleep disorders
smoking
sports medicine
statins
stds sexual health
stem cell research
stroke
terrorism
tropical diseases
ulcerative colitis crohns disease
urology nephrology
veterinary
water quality
womens health obgyn

feed contents

The Life Channel Becomes The Change4Life Channel
For the whole month of January, The Life Channel will be transforming its entire network branding in support of cross-government campaign, Change4Life. Aiming to help every family in England eat well, move more and live longer, Change4Life is a new movement supported by the Department of Health which primarily focuses on the issue of obesity in children.
medicalnewstoday.com

Health And Social Care Expected To Boost Apprenticeship Awards Entries, UK
The search is on to find the nation's top Apprenticeship employers as the Learning and Skills Council (LSC) launches its prestigious sixth annual Apprenticeship Awards. Employers of all sizes and from all sectors including health and social care are encouraged to enter.
medicalnewstoday.com

Adhezion Biomedical Receives FDA Marketing Clearance For SurgiSeal™ Topical Skin Adhesive New Topical Skin Adhesive Is Cleared For U.S. Launch
Adhezion Biomedical LLC, a medical device manufacturer, announced that the FDA has provided marketing clearance for its SurgiSeal (2-octyl cyanoacrylate) topical skin adhesive. SurgiSeal is the first and only 2-octyl cyanoacrylate that does not require an activator. It is indicated for use in surgical and emergency applications.
medicalnewstoday.com

ACADIA Pharmaceuticals Awarded Grant From The Michael J. Fox Foundation For The Development Of Novel ER-beta Agonists For The Treatment Of Parkinson
ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that it has been awarded a grant from The Michael J.
medicalnewstoday.com

Nomir Medical Announces Second FDA 510(k) Clearance Of Its Noveon(R) Dual-Wavelength Device
Nomir Medical Technologies, a leader in the development of optical energy technologies for medical applications, announced that the Food and Drug Administration (FDA) has granted a second clearance of the Company's advanced Noveon® system.
medicalnewstoday.com

Q-Med Has Obtained Registration Approval For Restylane(R) In China
Q-Med (STO:QMED) has obtained registration approval for Restylane® in China. An application for sales approval will be submitted shortly and it is estimated that sales of the product will begin at the end of the second quarter in 2009. "There is a large appetite for new things in China and great respect for products from the West.
medicalnewstoday.com

Ipsen: FDA's First-Cycle Review Of Reloxin(R) Extended
Ipsen (Paris:IPN) announced that the U.S. Food and Drug Administration (FDA) provided notification that the Prescription Drug User Fee Act (PDUFA) action date for Reloxin® (botulinum toxin of type A) Biologics License Application (BLA) in aesthetic indications (glabellar lines) has been extended to April 13, 2009. The FDA did not issue any specific request on the occasion of this extension.
medicalnewstoday.com

The Institute For Advanced Laser Dentistry Announces Impressive Line Up Of Speakers For 6TH Annual Clinicians' Meeting
The Institute for Advanced Laser Dentistry (IALD) announced its line up of industry-leading speakers for the highly anticipated 6th Annual Clinicians' Meeting, taking place February 11-15, 2009 (Valentine's and President's day weekend) at the luxurious Moon Palace Golf & Spa Resort in Cancun, Mexico.
medicalnewstoday.com

BioMimetic Therapeutics, Inc. Closes Enrollment With 436 Patients In North American Pivotal Study For Augment™ Bone Graft
BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced that as of December 31, 2008, 436 patients were enrolled in the Company's North American pivotal clinical study for its lead orthopedic product candidate Augment™ Bone Graft.
medicalnewstoday.com

Positive Results For Peplin's Phase IIb AK Trial
Peplin, Inc. (ASX:PLI) announced positive results with its lead product candidate PEP005 (ingenol mebutate) Gel in its Phase IIb actinic (solar) keratosis (AK) dose ranging clinical trial (PEP005-015) for the treatment of AK lesions on head locations, which comprise the face and scalp. AK is a common pre-cancerous skin condition caused by sun exposure.
medicalnewstoday.com

Cambridge Temperature Concepts Gains Medical Approval For Revolutionary Fertility Monitor DuoFertility And Ships First Units
Cambridge Temperature Concepts (CTC) announced receiving medical approval for their revolutionary non-invasive fertility monitor - DuoFertility. CTC have now begun shipping DuoFertility monitors to one hundred couples across Europe, selected by the Company to trial the device and give feedback on its usability and design before product launch.
medicalnewstoday.com

Enbrel Approved For Children With Psoriasis, Europe
The European Commission has granted marketing authorisation of the use of Enbrel® (etanercept) as the first biologic licensed for treatment in children and adolescents with chronic severe plaque psoriasis.
medicalnewstoday.com

South West Chlamydia Testing Team Beats National Average - Innovative Campaign Doubles Testing Rates In Six Months, UK
The Park Centre for Sexual Health at Weymouth Community Hospital is celebrating the success of its Chlamydia screening programme, which has screened more than 1,700 young people in the last five months alone, more than doubling its screen-rate and beating both local and national averages. Now, the campaign is being introduced to other Primary Care Trusts (PCT) across the country.
medicalnewstoday.com

The Movement Of Motion-defined Contours Can Bias Perceived Position
We are very good at visually localizing an object in space; however, it has been found that movement in the scene can cause us to perceive the position of an object shifted in the direction of the motion. Edges between moving areas can be easily perceived, but the movement of these edges cannot. We find that this type of motion can also shift the perceived position of objects.
medicalnewstoday.com

Supplementation With Vitamin E Or Selenium Does Not Reduce Risk Of Prostate Cancer
In perhaps the largest cancer chemoprevention trial ever conducted, researchers have found that supplementation with vitamin E or selenium, alone or in combination, was not associated with a lower risk of prostate cancer or other cancers.
medicalnewstoday.com

Treatment Involving Deep Brain Stimulation For Patients With Advanced Parkinson Disease Provides Benefits
Patients with advanced Parkinson disease (PD) who received deep brain stimulation treatment had more improvement in movement skills and quality of life after six months than patients who received other medical therapy, but also had a higher risk of a serious adverse events, according to a study in the January 7 issue of JAMA.
medicalnewstoday.com

How To Treat Fevers In African Children Up For Debate
A new debate in the open access journal PLoS Medicine questions whether all African children with fever should be treated presumptively with antimalarial drugs, or if treatment should wait until laboratory tests confirm malarial infection.
medicalnewstoday.com

Removing User Fees Does Not Improve Health Outcomes In Ghana
Removing user fees for primary health care changed health utilization behaviour but did not improve health outcomes among households with children under the age of five in Ghana, says a new study published in the open access journal PLoS Medicine.
medicalnewstoday.com

Obesity: Reviving The Promise Of Leptin - The First Known Leptin-sensitizing Agents Induce Mice To Lose Weight
The discovery more than a decade ago of leptin, an appetite-suppressing hormone secreted by fat tissue, generated headlines and great hopes for an effective treatment for obesity. But hopes dimmed when it was found that obese people are unresponsive to leptin due to development of leptin resistance in the brain.
medicalnewstoday.com

Deaths From Lung Cancer Could Be Reduced By Better Policies To Control Indoor Radon
About 1100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com today.
medicalnewstoday.com

Suboptimum Vaccination Coverage Raises Serious Doubts About Reaching Target Of Eliminating Measles In Europe By 2010
A study of measles data from 32 European countries* has revealed more than 12,000 cases of the disease in a two-year period (2006-07), mostly in unvaccinated or incompletely vaccinated children.
medicalnewstoday.com

PD2i Technology At Core Of Future Platforms For Risk Stratification Of Trauma And Sudden Cardiac Death
David H. Fater, President and CEO of Vicor Technologies, Inc., announced that on December 29, 2008 Vicor Technologies received FDA 510(k) approval (K082709) to market its PD2i Analyzer, permitting immediate commercialization of the technology. Vicor Technologies, Inc.
medicalnewstoday.com

Chemopreventive Agents In Black Raspberries Identified
A study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, identifies components of black raspberries with chemopreventive potential.
medicalnewstoday.com

Palonosetron Used With Dexamethasone Is Effective At Preventing Nausea And Vomiting After Chemotherapy
Palonosetron is as effective as, and in some ways better than, granisetron in preventing the nausea and vomiting that is often experienced after highly emetogenic chemotherapy, conclude the authors of a phase III comparator trial that is published in an Article Online first and in the February edition of The Lancet Oncology.
medicalnewstoday.com

MS Trust Given The Gift Of Radio Advertising, UK
Passion for the Planet, the UK's only radio station focused on helping people live a greener, healthier more ethical life has celebrated its sixth birthday by choosing charities to benefit from a free advertising campaign.
medicalnewstoday.com

University Lecturer Warns Of Rising Prevalence Of Type 2 Diabetes, UK
With the New Year inevitably comes the resolution of millions to get in shape. But shedding the pounds is now more important than ever - being overweight is the top factor in developing Type 2 diabetes.
medicalnewstoday.com

New Blog On Social Care And Palliative Care, UK
A new blog has been launched, by St Christopher's Hospice policy and development adviser, Malcolm Payne. It aims to keep social care professionals in touch with end-of-life care issues and raise awareness and understanding social care among palliative care professionals.
medicalnewstoday.com

Early Plans For The Roll Out Of Individual Health Record Approved
Information will help clinicians speed up diagnosis Plans to roll-out a system that will enable clinicians in hospital emergency departments and out-of-hours GPs to have access to important patient information to help with diagnosis and treatment have been approved by Health Minister Edwina Hart today.
medicalnewstoday.com

Mortality And Cancer Risks For Radiation Workers
The risk of developing cancer among radiation workers increases with the dose of ionising radiation they are exposed to, according to a study by the Health Protection Agency published today in the British Journal of Cancer *. The observed cancer risks are consistent with the international scientific consensus on radiation protection.
medicalnewstoday.com

KYTHERA Biopharmaceuticals Announces Positive Results From Two Phase 2 Studies With ATX-101 Demonstrating Reduction Of Submental Fat
KYTHERA Biopharmaceuticals, Inc. (KYTHERA) announced that it has successfully completed two Phase 2 clinical studies demonstrating the efficacy, safety, and tolerability of its lead product candidate, ATX-101, for the reduction of submental ('under-the-chin') fat.
medicalnewstoday.com

Genetics For The Public: First Annual Consumer Genetics Show In Boston June 9 -11, 2009
Show The First Annual Consumer Genetics announced that it will open its exhibit hall to the general public. The first conference of its kind, it will showcase both genetic testing companies offering a wide variety of products, as well as the genetic tool companies that enable the science in this emerging health care specialty.
medicalnewstoday.com

Cytori Expands Patent Protection For Celution(R) Stem & Regenerative Cell Processing System
Cytori (NASDAQ: CYTX) received U.S. Patent No. 7,473,420 (the '420 patent), which protects important formulations of the Celution® System output. This builds upon U.S. Patent No. 7,390,484, issued to Cytori in June 2008, which covers the Celution System technology for the bedside processing of stem and regenerative cells derived from adipose tissue.
medicalnewstoday.com

ArGentis Receives Favorable Opinion For European Orphan Drug Designation
arGentis Pharmaceuticals, LLC announced that the European Medicines Agency's (EMEA) Committee for Orphan Medicinal Products (COMP) adopted a positive opinion recommending the company's product candidate ARG201 (native type 1 bovine collagen) for the treatment of diffuse systemic sclerosis, also known
medicalnewstoday.com

KineMed Awarded Michael J. Fox Foundation Funding To Validate Translational Biomarker Of Microtubule Function In Parkinson's Disease
KineMed, Inc., a pathway-based drug discovery and development company, has been awarded a grant of up to $694,441 (if all milestones are met) to conduct clinical studies toward a new biomarker-based treatment for Parkinson's disease (PD).
medicalnewstoday.com

HWI Scientist First In World To Unravel Structure Of Key Breast Cancer Target Enzyme
The molecular details of Aromatase, the key enzyme required for the body to make estrogen, are no longer a mystery thanks to the structural biology work done by the Ghosh lab at the Hauptman-Woodward Medical Research Institute (HWI) in Buffalo, New York. Dr.
medicalnewstoday.com

QuantRx(R) Announces FDA 510(k) Clearance For Its RapidSense(R) Methamphetamine Test
QuantRx Biomedical Corporation (OTCBB: QTXB), a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, announced that the U.S. Food and Drug Administration (FDA) has granted the Company 510(k) clearance on its RapidSense drugs-of-abuse (DOA) Methamphetamine test.
medicalnewstoday.com

Health Care Delivery Could Be Adversely Affected By Cost Containment Focus
The drive toward containing health care costs could have the unintended consequence of reducing physician productivity, impairing quality and perhaps even increasing costs, two Beth Israel Deaconess Medical Center physicians suggest in a New England Journal of Medicine "Perspective.
medicalnewstoday.com

HHS Issues Action Plan To Prevent Health Care-Associated Infections
The U.S. Department of Health and Human Services (HHS) unveiled a plan that establishes a set of five-year national prevention targets to reduce and possibly eliminate health care-associated infections (HAIs). Health care-associated infections are infections that patients acquire while undergoing medical treatment or surgical procedures. These infections are largely preventable.
medicalnewstoday.com

Mountaineers Measure Lowest Human Blood Oxygen Levels On Record
The lowest ever levels of oxygen in humans have been reported in climbers on an expedition led by UCL (University College London) doctors.
medicalnewstoday.com

New Test Will Catch Sports Cheats On New Endurance Drugs
Avoiding detection just got harder for drug cheats who try to use a particular range of untested, but potentially enhancing, compounds. In the past, tests have been developed once a drug is known to be in circulation. Now a German research team has developed tests for a class of drugs that they believe could be used in the near future.
medicalnewstoday.com

Avian Flu Becoming More Resistant To Antiviral Drugs, Says University Of Colorado Study
A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.
medicalnewstoday.com

Cameron Health Commences Clinical Trial Of The Minimally Invasive Totally Subcutaneous Implantable Defibrillator For Treatment Of SCA
Cameron Health, Inc. announces the first CE trial implants in Europe and New Zealand for Cameron Health's Subcutaneous Implantable Defibrillator (S-ICD®) System. The minimally invasive S-ICD System is prescribed for use in patients at risk of Sudden Cardiac Arrest (SCA). The system is unique in that the implantation of the system is entirely subcutaneous; no leads are in or on the heart.
medicalnewstoday.com

Women's Access To Donated Kidneys Declines With Age, Particularly Compared With Men
Younger women have equivalent access to kidney transplants compared with their male counterparts, but older women receive transplants much less frequently than older men, according to a study appearing in the March 2009 issue of the Journal of the American Society Nephrology (JASN).
medicalnewstoday.com

Advaxis' Phase II Clinical Trial "HOLD" Lifted
Advaxis Inc (OTCBB: ADXS), a biotechnology company, received permission from the U. S. Food and Drug Administration (FDA) to test its lead drug candidate, Lovaxin C, in patients with grade 2/3 cervical intraepithelial neoplasia (CIN). With this approval of the Investigational New Drug (IND) application for Lovaxin C, the FDA "HOLD" on Advaxis' clinical program has been lifted.
medicalnewstoday.com

Initial Findings Could Lead To A New Approach For Treating Fragile X Syndrome
A pilot trial of an oral drug therapy called fenobam has shown promising initial results and could be a potential new treatment option for adult patients with Fragile X syndrome (FXS).
medicalnewstoday.com

The MDS Foundation Says VIDAZA Approval In Europe Could Provide Survival Benefits To Patients With Myelodysplastic Syndromes And Related Cancers
The Myelodysplastic Syndromes (MDS) Foundation applauds the European Commission's approval of VIDAZA (azacitidine) as an important advance for MDS patients in Europe. Vidaza represents an entirely new approach to treating cancer- it works by epigenetics, that is it helps restore the normal function of genes that regulate cell growth and development.
medicalnewstoday.com

Human Genomics In China
Ten years ago, the Chinese National Human Genome Center at Shanghai (South Center, hereafter) was established in the Zhangjiang HiTech Park of Pudong District in Shanghai. To commemorate this important event, which marks the beginning of the Genomics Era in China, we specially organize a series of mini-reviews for this special issue.
medicalnewstoday.com

Court Rules In Favor Of Medtronic In Fidelis Litigation
Medtronic, Inc. (NYSE: MDT) reported that on Jan. 5, the United States District Court for the District of Minnesota dismissed with prejudice the Master Consolidated Complaint for Individuals and the Master Consolidated Complaint for Third-Party Payors relating to the multi-district litigation (MDL) involving Medtronic's Sprint Fidelis defibrillator leads on grounds of federal preemption.
medicalnewstoday.com

Xenomics, Inc. Discusses HPV Screening Test Based On Transrenal DNA Technology At 52nd All India Congress Of Obstetrics & Gynecology
Xenomics, Inc. (XNOM.PK), a developer of non-invasive next-generation molecular diagnostics, announced today that Dr. Samuil Umansky, Chief Scientific Officer, presented at the 52nd All India Congress of Obstetrics & Gynecology (AICOG) in Jaipur, India. Dr.
medicalnewstoday.com

Winter Babies Face Socioeconomic Disadvantages
Many of us may often feel that we've been born under an unlucky sign. Now, new research by a pair of University of Notre Dame economists suggests that some of us are, in fact, born in an unlucky season.
medicalnewstoday.com

BASi Receives A European Patent For Culex(R)
BASi is proud to announce the awarding of the new European patent for their Culex® Automated In Vivo Sampling System. The patent is valid until 2019 and is effective in Germany, Denmark, France, UK and Sweden. The Culex Automated In Vivo Sampling System is designed to collect pharmacokinetic and pharmacodynamic (PK/PD) data during the course of drug metabolism experiments.
medicalnewstoday.com

Target Discovered That Could Ease Spinal Muscular Atrophy Symptoms
There is no cure for spinal muscular atrophy (SMA), a genetic disorder that causes the weakening of muscles and is the leading genetic cause of infant death, but University of Missouri researchers have discovered a new therapeutic target that improves deteriorating skeletal muscle tissue caused by SMA.
medicalnewstoday.com

U.S. Patent And Trademark Office Accepts Pfizer's Reissue Application On Lipitor Enantiomer Patent
Pfizer Inc announced that the U.S. Patent & Trademark Office has issued a "Notice of Allowance" accepting the company's application to correct the technical defect in the '995 enantiomer patent for atorvastatin calcium, the salt form of atorvastatin sold as Lipitor. The company noted that certain formalities must be completed before the reissue patent will be granted.
medicalnewstoday.com

Absence Of CLP Protein Can Be Indicative Of Oral Cancer
Human calmodulin-like protein (CLP) is found in many cell types including breast, thyroid, prostate, kidney, and skin. The protein can regulate many cell activities and has a highly specific expression.
medicalnewstoday.com

Don't Let 'iPatient' Detract From Hands-On Medicine, Stanford Author/Educator Urges
On his first day as attending physician at Stanford, Abraham Verghese, MD, suggested to the ward team that they leave the "bunker" and head out to their patients' bedsides. "They probably felt that everything I would need to get up to speed on our patients - the necessary images, the laboratory results - was right there in the team room," Verghese wrote in an essay in the Dec.
medicalnewstoday.com

Excessive Use Of Antiviral Drugs Could Aid Deadly Flu According To Study
Influenza's ability to resist the effects of cheap and popular antiviral agents in Asia and Russia should serve as a cautionary tale about U.S. plans to use the antiviral Tamiflu in the event of widespread avian flu infection in humans, scientists say.
medicalnewstoday.com

Unibioscreen Announces Progress Of Phase I Clinical Trial For UNBS1450 In Europe In Cancer Patients With Advanced Solid Tumors
Unibioscreen S.A., the Brussels-based specialist oncology company, is pleased to announce that the clinical testing of its second experimental anti-cancer drug, UNBS1450, which is being administered in cancer patients since October 2008, is progressing well.
medicalnewstoday.com

Perfectionist Protein-Maker Trashes Errors
The enzyme machine that translates a cell's DNA code into the proteins of life is nothing if not an editorial perfectionist.
medicalnewstoday.com

Control Of Blood Vessels A Possible Weapon Against Obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control blood vessel development in humans in order to combat obesity and diabetes. The growth of fat cells and their metabolism depend on oxygen and blood-borne nutrients.
medicalnewstoday.com

Risk Of Neonatal Illness Increased When C-Section Repeated Before 39 Weeks
Women choosing repeat cesarean deliveries and having them at term but before completing 39 weeks gestation are up to two times more likely to have a baby with serious complications including respiratory distress resulting in mechanical ventilation and NICU admission. UAB researchers, led by Alan T.N. Tita, M.D., Ph.D.
medicalnewstoday.com

HEADLINES News, Sports, Shopping, Travel information

Headlines - Rss Feed Directory